Last updated: October 12, 2023
Sponsor: AronPharma Sp. z o. o.
Overall Status: Active - Recruiting
Phase
N/A
Condition
Canker Sores
Mucositis
Treatment
Aerosol (Polyphenol-rich plant extracts, Hyaluronic Acid, Cetraria Islandica, Vitamin B3)
Clinical Study ID
NCT05994638
08-AP-ONCOS
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Women and men, 18-75 years old
- Patients with head and neck cancer or other types of cancer after radiotherapy whosuffer from oral mucositis
- Patients with dryness in mouth
- Signed informed consent.
Exclusion
Exclusion Criteria:
- Intake of supplements containing plant extracts, polyphenols or anthocyanins
- Participation in another clinical trial,
- Women who are pregnant, planning to become pregnant during the study or breastfeeding,
- Autoimmune disease, severe liver dysfunction, inflammatory bowel disease,tuberculosis, multiple sclerosis, AIDS, rheumatoid arthritis, organ transplantation.
- Hypersensitivity/allergy to any of the ingredient
Study Design
Total Participants: 10
Treatment Group(s): 1
Primary Treatment: Aerosol (Polyphenol-rich plant extracts, Hyaluronic Acid, Cetraria Islandica, Vitamin B3)
Phase:
Study Start date:
August 21, 2023
Estimated Completion Date:
November 30, 2023
Study Description
Connect with a study center
Uniwersyteckie Centrum Stomatologiczne GUMed
Gdańsk, 80-204
PolandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.